Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Not applicableStudy completedNCT00255671What this trial is testingAcute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersWho this might be right forBrain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity Case Comprehensive Cancer Center 76
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT01164189What this trial is testingBevacizumab in Recurrent Grade II and III GliomaWho this might be right forCentral Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 155
Not applicableWithdrawnNCT00005790What this trial is testingPerfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Northwestern University
Early research (Phase 1)Study completedNCT01480050What this trial is testingMibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent GliomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Early research (Phase 1)Study completedNCT00006025What this trial is testingTemozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00004688What this trial is testingPhase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsWho this might be right forAnaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more Emory University 35
Large-scale testing (Phase 3)Active Not RecruitingNCT00887146What this trial is testingRadiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade GliomaWho this might be right forBrain and Central Nervous System Tumors Alliance for Clinical Trials in Oncology 305
Early research (Phase 1)Ended earlyNCT00003567What this trial is testingGene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00354068What this trial is testingImatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Duke University 65
Early research (Phase 1)Study completedNCT01172964What this trial is testingA Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasWho this might be right forAdult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more City of Hope Medical Center 15
Not applicableEnded earlyNCT00756106What this trial is testingMRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaWho this might be right forBrain and Central Nervous System Tumors Massachusetts General Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT00062504What this trial is testingPhase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasWho this might be right forGlioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more Teva Branded Pharmaceutical Products R&D, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00667394What this trial is testingTandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00499473What this trial is testingSunitinib in Treating Patients With Recurrent Malignant GliomasWho this might be right forAdult Anaplastic AstrocytomaAdult Diffuse AstrocytomaAdult Giant Cell Glioblastoma+5 more National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT01051557What this trial is testingTemsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00003467What this trial is testingCarmustine in Treating Adults With Recurrent Supratentorial Low-Grade GliomaWho this might be right forBrain and Central Nervous System Tumors Duke University 68
Early research (Phase 1)Study completedNCT00080054What this trial is testingMotexafin Gadolinium and Temozolomide for the Treatment of Malignant GliomasWho this might be right forGliomaGlioblastomaAstrocytoma+2 more Pharmacyclics LLC. 24
Early research (Phase 1)Study completedNCT00784914What this trial is testingA Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMetastatic Cancer City of Hope Medical Center 12